Concepedia

Dennis C. Coffey

DC

Statistics

Publications

4

Citations

466

H-Index

4

Active since

1999

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Kettering University

Dennis C. Coffey is an author at Memorial Sloan Kettering Cancer Center specializing in cancer cell biology, medicine, and tumor biology.

Top concepts

Publications per year

1999–2003

4

Publications

4

Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.

Richard D. Glick, Steven Swendeman, Dennis C. Coffey et al. · PubMed · 1999 · 186 citations

, , +16

The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.

Dennis C. Coffey, Martha C. Kutko, Richard D. Glick et al. · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · 2001 · 157 citations

, , +14

Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro.

Martha C. Kutko, Richard D. Glick, Lisa M. Butler et al. · PubMed · 2003 · 64 citations

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro

Dennis C. Coffey, Martha C. Kutko, Richard D. Glick et al. · Medical and Pediatric Oncology · 2000 · 59 citations

1–4 of 4